A 25 year adventure in the field of tachykinins

Peptides

Volumn 25, Issue 3, 2004, Pages 339-357

  Beaujouan, Jean Claude ^a   Torrens, Yvette ^a   Saffroy, Monique ^a   Kemel, Marie Louise ^a   Glowinski, Jacques ^a  

^a INSERM   (France)

Author keywords

Autoradiography; Binding sites; Biological activities; Biosynthesis; Brain; NK1 receptor subtypes; NK1, NK 2, NK3 receptors; Release; Septide sensitive binding sites; Substance P; Tachykinin receptors; Tachykinins

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; NEUROPEPTIDE GAMMA; NEUROPEPTIDE K; PHYSALAEMIN[9 DEXTRO PROLINE SPIRO GAMMA LACTAM 10 LEUCINE 11 TRYPTOPHAN]; RECEPTOR SUBTYPE; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR AGONIST; TACHYKININ RECEPTOR ANTAGONIST;

ACETYLCHOLINE RELEASE; BASAL GANGLION; BINDING SITE; CORPUS STRIATUM; DOPAMINE RELEASE; HORMONE BINDING; HORMONE RELEASE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; RECEPTOR BINDING; REVIEW;

ANIMALS; BINDING SITES; CORPUS STRIATUM; HUMANS; PREFRONTAL CORTEX; RECEPTORS, TACHYKININ; SUBSTANCE P; SUBSTANTIA NIGRA; TACHYKININS;

EID: 2342559847     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.02.011     Document Type: Review

References (191)

1. Anderson J.J., Randall S., Chase T.N. The neurokinin1 receptor antagonist CP-99, 994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum. J. Pharmacol Exp Ther. 274(2):1995;928-936
2. Arai H., Emson P.C. Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system. Brain Res. 399:1986;240-249
3. Arai H., Sirinathsinghji D.J., Emson P.C. Depletion in substance P- and neurokinin A-like immunoreactivity in substantia nigra after ibotenate-induced lesions of striatum. Neurosci Res. 5:1987;167-171
4. Baker S.J., Morris J.L., Gibbins I.L. Cloning of a C-terminally truncated NK-1 receptor from guinea-pig nervous system. Brain Res Mol Brain Res. 111(1/2):2003;136-147
5. Baruch P., Artaud F., Godeheu G., Barbeito L., Glowinski J., Cheramy A. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons. Neuroscience. 25(3):1988;889-898
6. Beaujouan J.C., Torrens Y., Viger A., Glowinski J. A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative. Mol Pharmacol. 26(2):1984;248-254
7. Beaujouan J.C., Torrens Y., Saffroy M., Glowinski J. Quantitative autoradiographic analysis of the distribution of binding sites for [125I] Bolton Hunter derivatives of eledoisin and substance P in the rat brain. Neuroscience. 18(4):1986;857-875
8. Beaujouan J.C., Saffroy M., Torrens Y., Glowinski J. Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801. Eur J. Pharmacol. 319(2-3):1997;307-316
9. Beaujouan J.C., Saffroy M., Torrens Y., Glowinski J. Different subtypes of tachykinin NK(1) receptor binding sites are present in the rat brain. J. Neurochem. 75(3):2000;1015-1026
10. Beaujouan J.C., Saffroy M., Petitet F., Torrens Y., Glowinski J., Neuropeptide K. scyliorhinin I and II: new tools in the tachykinin receptor field. Eur J. Pharmacol. 151(2):1988;353-354
11. Beaujouan J.C., Saffroy M., Torrens Y., Sagan S., Glowinski J. Pharmacological characterization of tachykinin septide-sensitive binding sites in the rat submaxillary gland. Peptides. 20(11):1999;1347-1352
12. Beaujouan J.C., Torrens Y., Herbet A., Daguet M.C., Glowinski J., Prochiantz A. Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture. Mol Pharmacol. 22(1):1982;48-55
13. Beaujouan J.C., Daguet de Montety M.C., Torrens Y., Saffroy M., Dietl M., Glowinski J. Marked regional heterogeneity of 125I-Bolton Hunter substance P binding and substance P-induced activation of phospholipase C in astrocyte cultures from the embryonic or newborn rat. J. Neurochem. 54(2):1990;669-675
14. Beaujouan J.C., Teutsch B., Saffroy M., Petitet F., Torrens Y., Glowinski J. NK-1 receptors are the only class of tachykinin receptors found on mouse cortical astrocytes. Peptides. 12(4):1991;813-820
15. Beaujouan J.C., Heuillet E., Petitet F., Saffroy M., Torrens Y., Glowinski J. Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists. Br J. Pharmacol. 108(3):1993;793-800
16. Bensaid M., Faucheux B.A., Hirsch E., Agid Y., Soubrie P., Oury-Donat F. Expression of tachykinin NK2 receptor mRNA in human brain. Neurosci Lett. 303(1):2001;25-28
17. Beresford I.J., Birch P.J., Hagan R.M., Ireland S.J. Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96, 345. Br J. Pharmacol. 104(2):1991;292-293
18. Bergström L., Beaujouan J.C., Torrens Y., Saffroy M., Glowinski J. Sulfhydryl reagents have different effects on substance P and neurokinin B binding sites on cortical synaptosomes in the rat. Neuropeptides. 9(2):1987a;151-159
19. Bergström L., Torrens Y., Saffroy M., Beaujouan J.C., Lavielle S., Chassaing G., et al. [3H] neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain. J. Neurochem. 48(1):1987b;125-133
20. Bergström L., Beaujouan J.C., Torrens Y., Saffroy M., Glowinski J., Lavielle S., et al. 3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle. Mol Pharmacol. 32(6):1987c;764-771
21. Blanchet F., Kemel M.L., Gauchy C., Desban M., Perez S., Glowinski J. N-methyl-D-aspartate-evoked release of [3H] acetylcholine in striatal compartments of the rat: regulatory roles of dopamine and GABA. Neuroscience. 81(1):1997;113-127
22. Blanchet F., Gauchy C., Perez S., Soubrie P., Glowinski J., Kemel M.L. Distinct modifications by neurokinin1 (SR140333) and neurokinin2 (SR48968) tachykinin receptor antagonists of the N-methyl-D-aspartate-evoked release of acetylcholine in striosomes and matrix of the rat striatum. Neuroscience. 85(4):1998;1025-1036
23. Blanchet F., Gauchy C., Perez S., Soubrie P., Glowinski J., Kemel M.L. Control by GABA and tachykinins of the evoked release of acetylcholine in striatal compartments under different modalities of NMDA receptor stimulation. Brain Res. 853(1):2000;142-150
24. Brownstein M.J., Mroz E.A., Kizer J.S., Palkovits M., Leeman S.E. Regional distribution of substance P in the brain of the rat. Brain Res. 116(2):1976;299-305
25. Buck S.H., Burcher E., Shults C.W., Lovenberg W., O'Donohue T.L. Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor. Science. 226(4677):1984;987-989
26. Buck S.H., Helke C.J., Burcher E., Shults C.W., O'Donohue T.L. Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system. Peptides. 7(6):1986;1109-1120
27. Burcher E., Buck S.H., Lovenberg W., O'Donohue T.L. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder. J. Pharmacol Exp Ther. 236(3):1986;819-831
28. Burcher E., Mussap C.J., Geraghty D.P., McClure-Sharp J.M., Watkins D.J. Concepts in characterization of tachykinin receptors. Ann N Y Acad Sci. 632:1991;123-136
29. Cascieri M.A., Liang T. Characterization of the substance P receptor in rat brain cortex membranes and the inhibition of radioligand binding by guanine nucleotides. J. Biol Chem. 258(8):1983;5158-5164
30. Cellier E., Barbot L., Iyengar S., Couture R. Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat. Br J. Pharmacol. 127(3):1999;717-728
31. Charlton C.G., Helke C.J. Ontogeny of substance P receptors in rat spinal cord: quantitative changes in receptor number and differential expression in specific loci. Brain Res. 394(1):1986;81-91
32. Chassaing G., Lavielle S., Brunissen A., Carruette A., Garret C., Petitet F., et al. [Pro9] SP and [pGlu6] Pro9] SP(6-11) interact with two different receptors in the guinea-pig ileum as demonstrated with new SP antagonists. Neuropeptides. 23(2):1992;73-79
33. Chassaing G., Lavielle S., Loeuillet D., Robilliard P., Carruette A., Garret C., et al. Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay). Neuropeptides. 19(2):1991;91-95
34. Chéramy A., Nieoullon A., Michelot R., Glowinski J. Effects of intranigral applications of dopamine and ubstance P on the in vivo release of newly synthesized [3H]-dopamine in the ipsilateral caudate nucleus of the cat. Neurosci Lett. 4:1977;105-109
35. Chéramy A., Michelot R., Leviel V., Nieoullon A., Glowinski J., Kerdelhue B. Effect of the immunoneutralization of substance P in the cat substantia nigra on the release of dopamine from dendrites and terminals of dopaminergic neurons. Brain Res. 155(2):1978;404-408
36. Chesselet M.F. Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Neuroscience. 12(2):1984;347-375
37. Ciucci A., Palma C., Manzini S., Werge T.M. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide. Br J. Pharmacol. 125(2):1998;393-401
38. Dahan M., Levi S., Luccardini C., Rostaing P., Riveau B., Triller A. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science. 302(5644):2003;442-445
39. Dam T.V., Escher E., Quirion R. Evidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex. Brain Res. 453(1/2):1988;372-376
40. Danks J.A., Rothman R.B., Cascieri M.A., Chicchi G.G., Liang T., Herkenham M. A comparative autoradiographic study of the distributions of substance P and eledoisin binding sites in rat brain. Brain Res. 385(2):1986;273-281
41. Delumeau J.C., Petitet F., Cordier J., Glowinski J., Premont J. Synergistic regulation of cytosolic Ca2+ concentration in mouse astrocytes by NK1 tachykinin and adenosine agonists. J. Neurochem. 57(6):1991;2026-2035
42. Dietl M.M., Torrens Y., Beaujouan J.C., Glowinski J. Substance P-induced reduction in the initial accumulation of cytosolic myo-[3H] inositol in rat parotid acinar cells mediated by the NK1 tachykinin receptor. J. Neurochem. 53(5):1989;1640-1643
43. Diez-Guerra F.J., Sirinathsinghji D.J., Emson P.C. In vitro and in vivo release of neurokinin A-like immunoreactivity from rat substantia nigra. Neuroscience. 27(2):1988;527-536
44. Drapeau G., D'Orleans-Juste P., Dion S., Rhaleb N.E., Rouissi N.E., Regoli D. Selective agonists for substance P and neurokinin receptors. Neuropeptides. 10(1):1987;43-54
45. Elliott P.J., Mason G.S., Stephens-Smith M., Hagan R.M. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists. Neuropeptides. 19(2):1991;119-126
46. Emonds-Alt X., Vilain P., Goulaouic P., Proietto V., Van Broeck D., Advenier C., et al. A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. Life Sci. 50(15):1992;L101-L106
47. Emonds-Alt X., Bichon D., Ducoux J.P., Heaulme M., Miloux B., Poncelet M., et al. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sci. 56(1):1995;L27-L32
48. Erspamer V. The tachykinin peptide family. Trends Neurosci. 4:1981;267-269
49. Fong T.M., Yu H., Strader C.D. Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96, 345 and RP67580. J. Biol Chem. 267(36):1992b;25668-25671
50. Fong T.M., Anderson S.A., Yu H., Huang R.R., Strader C.D. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol Pharmacol. 41(1):1992a;24-30
51. Gauchy C., Desban M., Glowinski J., Kemel M.L. Distinct regulations by septide and the neurokinin-1 tachykinin receptor agonist [pro9] substance P of the N-methyl-D-aspartate-evoked release of dopamine in striosome- and matrix-enriched areas of the rat striatum. Neuroscience. 73(4):1996;929-939
52. Gauchy C., Beaujouan J.C., Besson M.J., Kerdelhue B., Glowinski J., Michelot R. Topographical distribution of substance P in the cat substantia nigra. Neurosci Lett. 12(1):1979;127-131
53. Gerfen CR, Wilson CJ. The basal ganglion. In: Swanson L, Bjorklund A, Hokfelt T, editors. Handbook of chemical neuroanatomy. Integrated system of the CNS, vol. 12. Amsterdam: Elsevier; 1996. p. 371-468.
54. Giardina G.A., Gagliardi S., Martinelli M. Antagonists at the neurokinin receptors - recent patent literature. IDrugs. 6(8):2003;758-772
55. Gitter B.D., Waters D.C., Bruns R.F., Mason N.R., Nixon J.A., Howbert J.J. Species differences in affinities of non-peptide antagonists for substance P receptors. Eur J. Pharmacol. 197(2/3):1991;237-238
56. Glowinski J. The 'septide-sensitive' tachykinin receptor: still an enigma. Trends Pharmacol Sci. 16(11):1995;365-367
57. Glowinski J., Michelot R., Cheramy A. Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurons. Adv Biochem Psychopharmacol. 22:1980;51-62
58. Glowinski J., Torrens Y., Saffroy M., Bergstrom L., Beaujouan J.C., Lavielle S., et al. Tachykinin receptors in the CNS. Prog Brain Res. 72:1987;197-203
59. Goode T., O'Connell J., Ho W.Z., O'Sullivan G.C., Collins J.K., Douglas S.D., et al. Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells. Clin Diagn Lab Immunol. 7(3):2000;371-376
60. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13(7):1990;244-254
61. Griebel G. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? Pharmacol Ther. 82(1):1999;1-61
62. Guard S., Watson S.P. Tachykinin receptor types: classification and membrane signalling mechanisms. Neurochem. Int. 18(2):1991;149-165
63. Guard S., Watling K.J., Watson S.P. Neurokinin3-receptors are linked to inositol phospholipid hydrolysis in the guinea-pig ileum longitudinal muscle-myenteric plexus preparation. Br J. Pharmacol. 94(1):1988;148-154
64. Hagan R.M., Beresford I.J., Stables J., Dupere J., Stubbs C.M., Elliott P.J., et al. Characterisation, CNS distribution and function of NK2 receptors studied using potent NK2 receptor antagonists. Regul Pept. 46(1/2):1993;9-19
65. Hall J.M., Flowers J.M., Morton I.K. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder. Br J. Pharmacol. 107(3):1992;777-784
66. Hall J.M., Caulfield M.P., Watson S.P., Guard S. Receptor subtypes or species homologues: relevance to drug discovery. Trends Pharmacol Sci. 14(10):1993;376-383
67. Hanley M.R., Sandberg B.E., Lee C.M., Iversen L.L., Brundish D.E., Wade R. Specific binding of 3H-substance P to rat brain membranes. Nature. 286(5775):1980;810-812
68. Harmar A., Schofield J.G., Keen P. Cycloheximide-sensitive synthesis of substance P by isolated dorsal root ganglia. Nature. 284(5753):1980;267-269
69. Hastrup H., Schwartz T.W. Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis. FEBS Lett. 399(3):1996;264-266
70. Henry JL. Discussions of nomenclature for tachykinins and tachykinin receptors. In: Henry JL, Couture R, Cuello AC, Pelletier G, Quirion R, Regoli D, editors. Substance P and neurokinins. New York: Springer-Verlag; 1987. p. xvii-xviii.
71. Herkenham M. Mismatches between neurotransmitter and receptor localizations in brain: observations and implications. Neuroscience. 23(1):1987;1-38
72. Hökfelt T., Pernow B., Wahren J. Substance P: a pioneer amongst neuropeptides. J. Intern Med. 249(1):2001;27-40
73. Hökfelt T., Kellerth J.O., Nilsson G., Pernow B. Substance p: localization in the central nervous system and in some primary sensory neurons. Science. 190(4217):1975;889-890
74. Holst B., Hastrup H., Raffetseder U., Martini L., Schwartz T.W. Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis. J. Biol Chem. 276(23):2001;19793-19799
75. Huang R.R., Huang D., Strader C.D., Fong T.M. Conformational compatibility as a basis of differential affinities of tachykinins for the neurokinin-1 receptor. Biochemistry. 34(50):1995;16467-16472
76. Iversen L.L. Nonopioid neuropeptides in mammalian CNS. Annu Rev Pharmacol Toxicol. 23:1983;1-27
77. Jensen R.T., Gardner J.D. Interaction of physalaemin, substance P, and eledoisin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci U.S.A. 76(11):1979;5679-5683
78. Kage R., Leeman S.E., Boyd N.D. Biochemical characterization of two different forms of the substance P receptor in rat submaxillary gland. J. Neurochem. 60(1):1993;347-351
79. Kanazawa I., Jessell T. Post mortem changes and regional distribution of substance P in the rat and mouse nervous system. Brain Res. 117(2):1976;362-367
80. Kemel M.L., Desban M., Glowinski J., Gauchy C. Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus. Proc Natl Acad Sci U.S.A. 86(22):1989;9006-9010
81. Kemel M.L., Perez S., Godeheu G., Soubrie P., Glowinski J. Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum. J. Neurosci. 22(5):2002;1929-1936
82. Kemel M.L., Perez S., Beaujouan J.C., Jabourian M., Soubrie P., Glowinski J. The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum. J. Neurochem. 87(2):2003;487-496
83. Kim H.R., Lavielle S., Sagan S. The two NK-1 binding sites are distinguished by one radiolabelled substance P analogue. Biochem Biophys Res Commun. 306(3):2003;725-729
84. Krause J.E., MacDonald M.R., Takeda Y. The polyprotein nature of substance P precursors. Bioessays. 10(2/3):1989;62-69
85. Krause JE, Blount P, Sachais BS. Molecular biology of receptors. Structures, expression and regulatory mechanism. In: Buck SH, editor. The tachykinin receptors. Totowa, NJ: Humana Press; 1994. p. 165-218.
86. Langlois X., Wintmolders C., te Riele P., Leysen J.E., Jurzak M. Detailed distribution of Neurokinin 3 receptors in the rat, guinea pig and gerbil brain: a comparative autoradiographic study. Neuropharmacology. 40(2):2001;242-253
87. Laufer R., Gilon C., Chorev M., Selinger Z. Desensitization with a selective agonist discriminates between multiple tachykinin receptors. J. Pharmacol Exp Ther. 245(2):1988;639-643
88. Lavielle S., Chassaing G., Julien S., Marquet A., Bergstrom L., Beaujouan J.C., et al. Specific recognition of SP or NKB receptors by analogues of SP substituted at positions 8 and 9. Eur J. Pharmacol. 125(3):1986;461-462
89. Lavielle S., Chassaing G., Loeuillet D., Convert O., Torrens Y., Beaujouan J.C., et al. Selective agonists of tachykinin binding sites. Fundam Clin Pharmacol. 4(3):1990;257-268
90. Lavielle S., Chassaing G., Brunissen A., Rodriguez M., Martinez J., Convert O., et al. Importance of the leucine side-chain to the spasmogenic activity and binding of substance P analogues. Int J. Pept Protein Res. 42(3):1993;270-277
91. Lecat S., Bucher B., Mely Y., Galzi J.L. Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses. J. Biol Chem. 277(44):2002;42034-42048
92. Lee J.M., McLean S., Maggio J.E., Zamir N., Roth R.H., Eskay R.L., et al. The localization and characterization of substance P and substance K in striatonigral neurons. Brain Res. 371(1):1986;152-154
93. Lee T., Kaneko T., Taki K., Mizuno N. Preprodynorphin-, preproenkephalin-, and preprotachykinin-expressing neurons in the rat neostriatum: an analysis by immunocytochemistry and retrograde tracing. J. Comp Neurol. 386(2):1997;229-244
94. Lessard A., Couture R. Modulation of cardiac activity by tachykinins in the rat substantia nigra. Br J. Pharmacol. 134(8):2001;1749-1759
95. Lew R., Geraghty D.P., Drapeau G., Regoli D., Burcher E. Binding characteristics of [125I] Bolton-Hunter [Sar9, Met(O2)11] substance P, a new selective radioligand for the NK1 receptor. Eur J. Pharmacol. 184(1):1990;97-108
96. Liang T., Cascieri M.A. Substance P receptor on parotid cell membranes. J. Neurosci. 1(10):1981;1133-1141
97. Lindefors N., Brodin E., Ungerstedt U. Neurokinin A and substance P in striato-nigral neurons in rat brain. Neuropeptides. 8(2):1986;127-132
98. Liu H., Brown J.L., Jasmin L., Maggio J.E., Vigna S.R., Mantyh P.W., et al. Synaptic relationship between substance P and the substance P receptor: light and electron microscopic characterization of the mismatch between neuropeptides and their receptors. Proc Natl Acad Sci U.S.A. 91(3):1994;1009-1013
99. Ljungdahl A., Hokfelt T., Nilsson G., Goldstein M. Distribution of substance P-like immunoreactivity in the central nervous system of the rat. II. Light microscopic localization in relation to catecholamine-containing neurons. Neuroscience. 3(10):1978;945-976
100. Lockerbie R.O., Beaujouan J.C., Saffroy M., Glowinski J. An isolated growth cone-enriched fraction from developing rat brain has substance P binding sites. Brain Res. 468(1):1988;1-9
101. Maggi C.A. The mammalian tachykinin receptors. Gen Pharmacol. 26(5):1995;911-944
102. Maggi C.A., Schwartz T.W. The dual nature of the tachykinin NK1 receptor. Trends Pharmacol Sci. 18(10):1997;351-355
103. Maggi C.A., Patacchini R., Giachetti A., Meli A. Tachykinin receptors in the circular muscle of the guinea-pig ileum. Br J. Pharmacol. 101(4):1990;996-1000
104. Mantyh P.W., Gates T., Mantyh C.R., Maggio J.E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J. Neurosci. 9(1):1989a;258-279
105. Mantyh P.W., Rogers S.D., Ghilardi J.R., Maggio J.E., Mantyh C.R., Vigna S.R. Differential expression of two isoforms of the neurokinin-1 (substance P) receptor in vivo. Brain Res. 719(1/2):1996;8-13
106. Mantyh P.W., Johnson D.J., Boehmer C.G., Catton M.D., Vinters H.V., Maggio J.E., et al. Substance P receptor binding sites are expressed by glia in vivo after neuronal injury. Proc Natl Acad Sci U.S.A. 86(13):1989b;5193-5197
107. Maubach K.A., Jones R.S. Electrophysiological characterisation of tachykinin receptors in the rat nucleus of the solitary tract and dorsal motor nucleus of the vagus in vitro. Br J. Pharmacol. 122(6):1997;1151-1159
108. Meini S., Patacchini R., Maggi C.A. Tachykinin NK1 receptor subtypes in the rat urinary bladder. Br J. Pharmacol. 111(3):1994;739-746
109. Michelot R., Leviel V., Giorguieff-Chesselet M.F., Cheramy A., Glowinski J. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways. Life Sci. 24(8):1979a;715-723
110. Michelot R., Leviel V., Torrens Y., Glowinski J., Cheramy A. In vivo release of substance P in the cat substantia nigra. Neurosci Lett. 15(2-3):1979b;141-146
111. Michelot R., Gozlan H., Beaujouan J.C., Besson M.J., Torrens Y., Glowinski J. Synthesis and biological activities of substance P iodinated derivatives. Biochem Biophys Res Commun. 95(2):1980;491-498
112. Mileusnic D., Lee J.M., Magnuson D.J., Hejna M.J., Krause J.E., Lorens J.B., et al. Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study. Neuroscience. 89(4):1999;1269-1290
113. Mitsuhashi M., Ohashi Y., Shichijo S., Christian C., Sudduth-Klinger J., Harrowe G., et al. Multiple intracellular signaling pathways of the neuropeptide substance P receptor. J. Neurosci Res. 32(3):1992;437-443
114. Mohini P., Bahouth S.W., Brundish D.E., Musacchio J.M. Specific labeling of rat brain substance P receptor with [3H] physalaemin. J. Neurosci. 5(8):1985;2078-2085
115. Murray M., Saffroy M., Torrens Y., Beaujouan J.C., Glowinski J. Tachykinin binding sites in the interpeduncular nucleus of the rat: normal distribution, postnatal development and the effects of lesions. Brain Res. 459(1):1988;76-92
116. Mussap C.J., Geraghty D.P., Burcher E. Tachykinin receptors: a radioligand binding perspective. J. Neurochem. 60(6):1993;1987-2009
117. Nakajima Y., Tsuchida K., Negishi M., Ito S., Nakanishi S. Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. J. Biol Chem. 267(4):1992;2437-2442
118. Nakanishi S. Substance P precursor and kininogen: their structures, gene organizations, and regulation. Physiol Rev. 67(4):1987;1117-1142
119. Nakanishi S. Mammalian tachykinin receptors. Annu Rev Neurosci. 14:1991;123-136
120. Nakaya Y., Kaneko T., Shigemoto R., Nakanishi S., Mizuno N. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J. Comp Neurol. 347(2):1994;249-274
121. Nevin K., Zhuo H., Helke C.J. Neurokinin A coexists with substance P and serotonin in ventral medullary spinally projecting neurons of the rat. Peptides. 15(6):1994;1003-1011
122. Nieoullon A., Cheramy A., Glowinski J. Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat. Brain Res. 145(1):1978;69-83
123. Ninkovic M., Beaujouan J.C., Torrens Y., Saffroy M., Hall M.D., Glowinski J. Differential localization of tachykinin receptors in rat spinal cord. Eur J. Pharmacol. 106(2):1984;463-464
124. Otsuka M., Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev. 73(2):1993;229-308
125. Palanche T., Ilien B., Zoffmann S., Reck M.P., Bucher B., Edelstein S.J., et al. The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. J. Biol Chem. 276(37):2001;34853-34861
126. Patacchini R., Maggi C.A. Tachykinin receptors and receptor subtypes. Arch Int Pharmacodyn Ther. 329(1):1995;161-184
127. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1997.
128. Petit F., Glowinski J. Stimulatory effect of substance P on the spontaneous release of newly synthesized [3H] dopamine from rat striatal slices: a tetrodotoxin-sensitive process. Neuropharmacology. 25(9):1986;1015-1021
129. Petitet F., Glowinski J., Beaujouan J.C. Evoked release of acetylcholine in the rat striatum by stimulation of tachykinin NK-1 receptors. Eur J. Pharmacol. 192(1):1991b;203-204
130. Petitet F., Beaujouan J.C., Saffroy M., Torrens Y., Glowinski J. The nonpeptide NK-2 antagonist SR 48968 is also a NK-3 antagonist in the guinea but not in the rat. Biochem Biophys Res Commun. 191(1):1993b;180-187
131. Petitet F., Saffroy M., Torrens Y., Glowinski J., Beaujouan J.C. A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum. Eur J. Pharmacol. 247(2):1993c;185-191
132. Petitet F., Beaujouan J.C., Saffroy M., Torrens Y., Fardin V., Glowinski J. NK-1 tachykinin receptor in rat and guinea pig brains: pharmacological and autoradiographical evidence for a species difference. Peptides. 14(3):1993a;551-559
133. Petitet F., Saffroy M., Torrens Y., Lavielle S., Chassaing G., Loeuillet D., et al. Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Peptides. 13(2):1992;383-388
134. Petitet F., Beaujouan J.C., Saffroy M., Torrens Y., Chassaing G., Lavielle S., et al. Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors. J. Neurochem. 56(3):1991a;879-889
135. Picard P., Regoli D., Couture R. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists. Br J. Pharmacol. 112(1):1994;240-249
136. Ploux O., Lavielle S., Chassaing G., Julien S., Marquet A., d'Orleans-Juste P., et al. Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B. Proc Natl Acad Sci U.S.A. 84(22):1987;8095-8099
137. Polidori C., Ciccocioppo R., De Caro G., Massi M. Further evidence that central tachykinin NK-1 receptors mediate the inhibitory effect of tachykinins on angiotensin-induced drinking in rats. Peptides. 19(1):1998;149-155
138. Powell D., Leeman S., Tregear G.W., Niall H.D., Potts J.T. Jr. Radioimmunoassay for substance P. Nat New Biol. 241(112):1973;252-254
139. Pradier L., Menager J., Le Guern J., Bock M.D., Heuillet E., Fardin V., et al. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P. Mol Pharmacol. 45(2):1994;287-293
140. Prat A., Picard P., Couture R. Cardiovascular and behavioural effects of centrally administered neuropeptide K in the rat: receptor characterization. Br J. Pharmacol. 112(1):1994;250-256
141. Putney J.W. Jr., Van de Walle C.M., Wheeler C.S. Binding of 125I-physalaemin to rat parotid acinar cells. J. Physiol. 301:1980;205-212
142. Quartara L., Maggi C.A. The tachykinin NK1 receptor. Part I. ligands and mechanisms of cellular activation. Neuropeptides. 31(6):1997;537-563
143. Quirion R., Pilapil C. Comparative potencies of substance P, substance K and neuromedin K on brain substance P receptors. Neuropeptides. 4(4):1984;325-329
144. Quirion R., Dam T.V. Ontogeny of substance P receptor binding sites in rat brain. J. Neurosci. 6(8):1986;2187-2199
145. Quirion R., Dam T.V., Guard S. Selective neurokinin receptor radioligands. Ann N Y Acad Sci. 632:1991;137-144
146. Quirion R., Shults C.W., Moody T.W., Pert C.B., Chase T.N., O'Donohue T.L. Autoradiographic distribution of substance P receptors in rat central nervous system. Nature. 303(5919):1983;714-716
147. Regoli D., Boudon A., Fauchere J.L. Receptors and antagonists for substance P and related peptides. Pharmacol Rev. 46(4):1994;551-599
148. Reid M.S., Herrera-Marschitz M., Hokfelt T., Ohlin M., Valentino K.L., Ungerstedt U. Effects of intranigral substance P and neurokinin A on striatal dopamine release. I. Interactions with substance P antagonists. Neuroscience. 36(3):1990;643-658
149. Reisine T., Soubrie P., Artaud F., Glowinski J. Application of L-glutamic acid and substance P to the substantia nigra modulates in vivo [3H] serotonin release in the basal ganglia of the cat. Brain Res. 236(2):1982a;317-327
150. Reisine T.D., Soubrie P., Artaud F., Glowinski J. Involvement of lateral habenula-dorsal raphe neurons in the differential regulation of striatal and nigral serotonergic transmission cats. J. Neurosci. 2(8):1982b;1062-1071
151. Rovero P., Pestellini V., Rhaleb N.E., Dion S., Rouissi N., Tousignant C., et al. Structure-activity studies of neurokinin A. Neuropeptides. 13(4):1989;263-270
152. Rupniak N.M. New insights into the antidepressant actions of substance P (NK1 receptor) antagonists. Can J. Physiol Pharmacol. 80(5):2002;489-494
153. Saffroy M., Torrens Y., Glowinski J., Beaujouan J.C. Presence of NK2 binding sites in the rat brain. J. Neurochem. 79(5):2001;985-996
154. Saffroy M., Torrens Y., Glowinski J., Beaujouan J.C. Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites. Neuroscience. 116(3):2003;761-773
155. Saffroy M., Beaujouan J.C., Petitet F., Torrens Y., Glowinski J. Differential localization of 3H-[Pro9] SP binding sites in the guinea pig and rat brain. Brain Res. 633(1/2):1994;317-325
156. Saffroy M., Beaujouan J.C., Torrens Y., Besseyre J., Bergström L., Glowinski J. Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain. Peptides. 9(2):1988;227-241
157. Sagan S., Lavielle S. Internalization of [3H] substance P analogues in NK-1 receptor transfected CHO cells. Biochem Biophys Res Commun. 282(4):2001;958-964
158. Sagan S., Beaujouan J.C., Torrens Y., Saffroy M., Chassaing G., Glowinski J., et al. High affinity binding of [3H] propionyl-[Met(O2)11] substance P(7-11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands. Mol Pharmacol. 52(1):1997;120-127
159. Saigo A., Takano Y., Saito R., Nakayama Y., Honda K., Kamiya H. Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96, 345, of substance P NK-1 receptor. Regul Pept. 46(1/2):1993;293-296
160. Sasai Y., Nakanishi S. Molecular characterization of rat substance K receptor and its mRNAs. Biochem Biophys Res Commun. 165(2):1989;695-702
161. Shults C.W., Johnston P., Gage F.H. Comparison of substance K-like and substance P-like fibers and cells in the rat hippocampus. Brain Res. 426(2):1987;290-296
162. Shults C.W., Quirion R., Chronwall B., Chase T.N., O'Donohue T.L. A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system. Peptides. 5(6):1984;1097-1128
163. Sjodin L., Brodin E., Nilsson G., Conlon T.P. Interaction of substance P with dispersed pancreatic acinar cells from the guinea pig. Binding of radioiodinated peptide. Acta Physiol Scand. 109(1):1980;97-105
164. Snider R.M., Constantine J.W., Lowe J.A. III, Longo K.P., Lebel W.S., Woody H.A., et al. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science. 251(499):1991;435-437
165. Soubrié P., Reisine T.D., Glowinski J. Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique. Neuroscience. 13(3):1984;605-625
166. Steinberg R., Souilhac J., Rodier D., Alonso R., Emonds-Alt X., Le Fur G., et al. Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation. Neuroscience. 84(2):1998b;511-518
167. Steinberg R., Marco N., Voutsinos B., Bensaid M., Rodier D., Souilhac J., et al. Expression and presence of septal neurokinin-2 receptors controlling hippocampal acetylcholine release during sensory stimulation in rat. Eur J. Neurosci. 10(7):1998;2337-2345
168. Stoessl A.J., Hill D.R. Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H] senktide. Brain Res. 534(1/2):1990;1-7
169. Takeda Y., Takeda J., Smart B.M., Krause J.E. Regional distribution of neuropeptide gamma and other tachykinin peptides derived from the substance P gene in the rat. Regul Pept. 28(3):1990;323-333
170. Takeda Y., Blount P., Sachais B.S., Hershey A.D., Raddatz R., Krause J.E. Ligand binding kinetics of substance P and neurokinin A receptors stably expressed in Chinese hamster ovary cells and evidence for differential stimulation of inositol 1, 4, 5-trisphosphate and cyclic AMP second messenger responses. J. Neurochem. 59(2):1992;740-745
171. Torrens Y., Beaujouan J.C., Viger A., Glowinski J. Properties of a 125I-substance P derivative binding to synaptosomes from various brain structures and the spinal cord of the rat. Naunyn Schmiedebergs Arch Pharmacol. 324(2):1983;134-139
172. Torrens Y., Dietl M., Beaujouan J.C., Glowinski J. Inhibitory effects of substance P and carbachol on the saturable sodium-dependent uptake process of myo-inositol in rat parotid gland. J. Pharmacol Exp Ther. 258(2):1991b;639-646
173. Torrens Y., Dietl M.M., Beaujouan J.C., Glowinski J. Myoinositol uptake in rat parotid gland, A selective bioassay for NK1 receptors. Ann N Y Acad Sci. 632:1991c;145-153
174. Torrens Y., Beaujouan J.C., Saffroy M., Glowinski J. Involvement of septide-sensitive tachykinin receptors in inositol phospholipid hydrolysis in the rat urinary bladder. Peptides. 16(4):1995;587-594
175. Torrens Y., Saffroy M., Glowinski J., Beaujouan J.C. Substance P(6-11) and natural tachykinins interact with septide-sensitive tachykinin receptors coupled to a phospholipase C in the rat urinary bladder. Neuropeptides. 31(3):1997;243-251
176. Torrens Y., Beaujouan J.C., Saffroy M., Glowinski J. Further evidence for the presence of "septide-sensitive" tachykinin binding sites in tissues possessing solely NK(1) tachykinin receptors. Biochem Biophys Res Commun. 270(2):2000;668-672
177. Torrens Y., Beaujouan J.C., Besson M.J., Michelot R., Glowinski J. Inhibitory effects of GABA, L-glutamic acid and nicotine on the potassium-evoked release of substance P in substantia nigra slices of the rat. Eur J. Pharmacol. 71(4):1981;383-392
178. Torrens Y., Michelot R., Beaujouan J.C., Glowinski J., Bockaert J. In vivo biosynthesis of 35S-substance P from [35S] methionine in the rat striatum and its transport to the substantia nigra. J. Neurochem. 38(6):1982;1728-1734
179. Torrens Y., Daguet De Montety M.C., el Etr M., Beaujouan J.C., Glowinski J. Tachykinin receptors of the NK1 type (substance P) coupled positively to phospholipase C on cortical astrocytes from the newborn mouse in primary culture. J. Neurochem. 52(6):1989;1913-1918
180. Torrens Y., Beaujouan J.C., Saffroy M., Glowinski J., Tence M. Functional coupling of the NK1 tachykinin receptor to phospholipase D in chinese hamster ovary cells and astrocytoma cells. J. Neurochem. 70(5):1998;2091-2098
181. Torrens Y., Lavielle S., Chassaing G., Marquet A., Glowinski J., Beaujouan J.C., et al. A tool to further distinguish two central tachykinin binding sites. Eur J. Pharmacol. 102(2):1984;381-382
182. Torrens Y., Beaujouan J.C., Saffroy M., Daguet de Montety M.C., Bergstrom L., Glowinski J. Substance P receptors in primary cultures of cortical astrocytes from the mouse. Proc Natl Acad Sci U.S.A. 83(23):1986;9216-9220
183. Torrens Y, Beaujouan JC, Dietl M, Saffroy M, Petitet F, Glowinski J. Tachykinin receptors: binding and cellular activity assays. In: Conn PM, editor. Methods in neurosciences. Neuropeptide technology: gene expression and neuropeptide receptors, vol. 5. NY: Academic Press; 1991. p. 243-67.
184. Tremblay L., Kemel M.L., Desban M., Gauchy C., Glowinski J. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors. Proc Natl Acad Sci U.S.A. 89(23):1992;11214-11218
185. Triller A., Choquet D. Synaptic structure and diffusion dynamics of synaptic receptors. Biol Cell. 95(7):2003;465-476
186. Tschöpe C., Jost N., Unger T., Culman J. Central cardiovascular and behavioral effects of carboxy- and amino-terminal fragments of substance P in conscious rats. Brain Res. 690(1):1995;15-24
187. Valentino K.L., Tatemoto K., Hunter J., Barchas J.D. Distribution of neuropeptide K-immunoreactivity in the rat central nervous system. Peptides. 7(6):1986;1043-1059
188. Viger A., Beaujouan J.C., Torrens Y., Glowinski J. Specific binding of a 125I-substance P derivative to rat brain synaptosomes. J. Neurochem. 40(4):1983;1030-1039
189. Watling K.J., Guard S., Boyle S.J., McKnight A.T., Woodruff G.N. Species variants of tachykinin receptor types. Biochem Soc Trans. 22(1):1994;118-122
190. Watling K.J., Guard S., Krause J.E., Takeda Y., Quirion R., Zarnegar R., et al. On the presence of NK2 receptor subtypes in peripheral and central tissues. Regul Pept. 46(1/2):1993;311-313
191. Wormser U., Laufer R., Hart Y., Chorev M., Gilon C., Selinger Z. Highly selective agonists for substance P receptor subtypes. Embo J. 5(11):1986;2805-2808